Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?
Marc BigaudPamela RamseierSarah TisserandMeike LangBeatrice UrbanChristian BeerliGöril KarlssonPublished in: Neurology and therapy (2023)
DER may be a key differentiator for siponimod over fingolimod for clinical efficacy in PMS.
Keyphrases